Drug-Only approach may prevent Post-Procedure pancreatitis without stent risks

NCT ID NCT07117318

Recruiting now Prevention Sponsor: Air Force Military Medical University, China Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two ways to prevent pancreatitis after a procedure called ERCP: giving a rectal anti-inflammatory drug (NSAID) alone versus the drug plus placing a small tube (stent) in the pancreas. The trial enrolls about 1,278 high-risk patients aged 18-90 who have not had prior pancreatic stenting. The goal is to see if the drug alone works just as well, avoiding the extra complexity and risks of stent placement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute pancreatitis prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-STEROID ANTI-INFLAMMATORY DRUGS PANCREATIC DUCT STENT PLACEMENT POST-ERCP ACUTE PANCREATITIS

Contacts and locations

Locations

986 Hospital of Xijing Hospital
RECRUITING

Xi'an, Shaanxi, 710000, China
Affiliated Hangzhou First People's Hospital
NOT_YET_RECRUITING

Hangzhou, Zhejiang, 310000, China
Department of Endoscopy, Eastern Hepatobiliary Hospital, Second Military Medical University
RECRUITING

Shanghai, Shanghai Municipality, 201823, China
Department of Gastroenterology, Fujian Medical University Xiamen Humanity Hospital
RECRUITING

Xiamen, Fujian, 361000, China
Department of Gastroenterology, Huaihe Hospital of Henan University
RECRUITING

Kaifeng, Henan, 475000, China
Department of Gastroenterology, The 960th Hospital of the PLA
RECRUITING

Jinan, Shandong, 250000, China
Department of gastroenterology, Second Affiliated Hospital of Chongqing Medical University
RECRUITING

Chongqing, Chongqing Municipality, 400010, China
Harbin Medical University Affiliated Fourth Hospital
RECRUITING

Harbin, Heilongjiang, 150000, China
Shandong Provincial Third Hospital
NOT_YET_RECRUITING

Jinan, Shandong, 250000, China
The Second Affiliated Hospital of Harbin Medical University
RECRUITING

Harbin, Heilongjiang, 150000, China
The Third Xiangya Hospital of Central South University
NOT_YET_RECRUITING

Changsha, Hunan, 410000, China
The first medical center, Chinese PLA General Hospital
NOT_YET_RECRUITING

Beijing, Beijing Municipality, 100000, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITING

Wuhan, Hubei, 430000, China
Xijing of Digestive Diseases
RECRUITING

Xi'an, Shaanxi, China
the First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITING

Hangzhou, Zhejiang, 310000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.